Military HIV Clinical Network
Official title: The Military HIV Research Program (MHRP) Clinical Trial Unit
Funded at Henry M. Jackson Fdn for the Adv Mil/med · NIH-11459071 · Data updated 2026-11-12
This program runs HIV and TB prevention and treatment clinical studies for adults in military-associated and high-HIV-burden communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry M. Jackson Fdn for the Adv Mil/med NIH-funded |
| Lab location | 1 site (Bethesda, United States) |
| Project start | December 10, 2013 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $75,000 |
| NIH project number | 3UM1AI108568-13S2 |
| Project ID | NIH-11459071 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults (21+) who live near participating sites and who are living with, at risk for, or eligible for HIV vaccine, prevention, or TB-related clinical protocols.
✕Less likely to help
People under age 21, those who live far from participating sites, or those who do not meet specific trial eligibility criteria are unlikely to benefit directly from enrollment.
What this research studies
You would be connecting with a network led by the Walter Reed Army Institute of Research and the Henry M. Jackson Foundation that runs clinical work at eight international sites in Africa and Asia plus U.S. support. The network supports vaccine, prevention, and treatment protocols from early safety studies to large efficacy trials through partnerships with HVTN, HPTN, ACTG and IAVI. Sites enroll adults and collect medical data, samples, and follow-up visits to test new HIV and TB vaccines and therapies. The goal is to speed safe, effective options to people living with or at risk for HIV and TB in high-burden areas.
Why it matters
Potential benefit: If successful, this network could accelerate access to better HIV vaccines, prevention tools, and TB treatments in communities with high disease burden.
How similar studies have gone: Previous clinical trial networks have supported important HIV prevention and treatment advances, though an effective, widely protective HIV vaccine remains an ongoing challenge.
Where this research is happening
-
Henry M. Jackson Fdn for the Adv Mil/med
Bethesda, United States Active
Researchers
- Principal investigator: Robb, Merlin L — Henry M. Jackson Fdn for the Adv Mil/med
- Study coordinator: Robb, Merlin L
Related research
Other NIH-funded projects on the same topics.
-
Cooperation partners of SETBP1 in AML development
This grant explores how SETBP1 and AF9 (MLLT3) work together to drive acute myeloid leukemia and whether targeting related epigenetic regulators could help treat aggressive CK-AML.
-
U.S. Military HIV Research Program Clinical Trials Unit expansion
A nationwide network of clinical trial sites is being expanded to test HIV prevention and treatment approaches through DAIDS-supported trials.
-
Novel protein biomarkers of chronic pain in adults using a pain registry biobank
A study in adults with chronic pain will look for new protein biomarkers in blood samples to understand better why pain persists and how to improve treatment.
-
Tailored antibody cures for HIV using AI and vaccines
A study to design personalized antibody-based strategies to achieve HIV remission, using lab experiments and computer models to tailor vaccines or antibody treatments to individuals or small groups.
-
Understanding how antibody protection works using 3D protein structures
Researchers will build a 3D-based method to see which viral features relate to prevention by antibodies, using data from people in HIV vaccine and monoclonal antibody trials.
-
Military HIV Clinical Trials Unit
This program runs clinical trials of new HIV vaccines, prevention approaches, and TB treatments for adults at risk of or living with HIV.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.